ROC Imposes Penalty on AstraZeneca Pharma India Over Delayed Regulatory Filings
AstraZeneca Pharma India Ltd 路 Others (Uncategorized) 路 18 Sept 2026, 10:26 pm
ROC Imposes Penalty on AstraZeneca Pharma India Over Delayed Regulatory Filings AstraZeneca Pharma India Limited received an adjudication order from the Registrar of Companies (ROC), Bengaluru, on 17th Sep'26, imposing a penalty of Rs. 1,88,000 on the company and Rs. 50,000 each on erstwhile officers-in-default. The penalty under Section 454 of the Companies Act, 2013 pertains to a delay in filing Form MR-2 regarding the 2023 appointment of former Managing Director Dr. Sanjeev Kumar Panchal. The company attributed the delay to technical glitches on the MCA portal regarding DIN status, which was rectified in Aug'23.
Original exchange filing (PDF)
More announcements from AstraZeneca Pharma India Ltd
- Please find the enclosed document of the Company as per the captioned subject. This is being resubmitted as the weblink was not correctly re-directing to the relevant web page in the earlier .... 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 17 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 07 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about General Updates 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 06 Nov 2026
- Please find the enclosed intimation of the Company as per the captioned subject for your reference. 路 05 Nov 2026
- AstraZeneca Pharma India Limited has informed the Exchange about Appointment/ Change in designation of Senior Management Personnel 路 05 Nov 2026
